Stelexis BioSciences Revenue

Biotechnology Research • Manhattan, New York, United States • 11-20 Employees

Stelexis BioSciences revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	$43,000,000

Key Contacts at Stelexis BioSciences

Manuel Aivado

President, Ceo And Board Director

John Sudzina

Director, Clinical Operations & Data Management

Jiahao Chen

Associate Director

Lynn Biderman

Associate Director

Company overview

Headquarters	780 3rd Ave, New York, NY 10017, US
Website	stelexis.com
SIC	873
Keywords	New York, Drug Discovery, Cancer Therapeutics
Founded	2017
Employees	11-20
Socials

Stelexis BioSciences Email Formats

Stelexis BioSciences uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@stelexis.com), used 50% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@stelexis.com	50%
{first initial}{last name}	jdoe@stelexis.com	40%
{second initial}{last name}	odoe@stelexis.com	10%

About Stelexis BioSciences

Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through the discovery and development of novel drugs.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Director

Vice President

Employees by Department

Stelexis BioSciences has 7 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Stelexis BioSciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-02-08	4	$43,000,000

Funding Insights

$43,000,000

Total funding amount

$43,000,000

Most recent funding amount

Number of funding rounds

Stelexis BioSciences Tech Stack

Discover the technologies and tools that power Stelexis BioSciences's digital infrastructure, from frameworks to analytics platforms.

Twitter Emoji

Font scripts

Amazon Web Services

PaaS

Amazon SES

Google Tag Manager

Tag managers

jQuery

JavaScript libraries

PHP

Programming languages

Open Graph

Miscellaneous

Flywheel

Hosting

WordPress

Blogs

jQuery Migrate

JavaScript libraries

Bootstrap

UI frameworks

Google Analytics

Analytics

Frequently asked questions

Stelexis BioSciences is located in Manhattan, New York, US.

Stelexis BioSciences generates an estimated annual revenue of $1,283,325. This revenue figure reflects the company's market position and business performance in its industry.

Stelexis BioSciences has an estimated valuation of $4,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Stelexis BioSciences was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Stelexis BioSciences has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Stelexis BioSciences has raised a total of $43,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Stelexis BioSciences

Manuel Aivado

President, Ceo And Board Director

John Sudzina

Director, Clinical Operations & Data Management

Jiahao Chen

Associate Director

Lynn Biderman

Associate Director

4.8

40,000 users